Original Research
Published on 04 Dec 2024
Mid-term follow-up results of neoadjuvant sintilimab combined with chemotherapy for locally advanced resectable esophageal squamous cell carcinoma
in Cancer Immunity and Immunotherapy
- 2,582 views
- 6 citations









